Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Cell death protein 3 homolog | 0.0455 | 0.4193 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1535 | 0.1437 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0089 | 0.0306 | 0.0194 |
Entamoeba histolytica | hypothetical protein | 0.0071 | 0.0115 | 0.5 |
Plasmodium falciparum | metacaspase-like protein | 0.0366 | 0.3247 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0366 | 0.3247 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0071 | 0.0115 | 0.5 |
Plasmodium vivax | metacaspase 1, putative | 0.0366 | 0.3247 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0295 | 0.2493 | 0.5945 |
Entamoeba histolytica | hypothetical protein | 0.0071 | 0.0115 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0366 | 0.3247 | 0.7744 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.1001 | 1 | 1 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0366 | 0.3247 | 0.3169 |
Echinococcus granulosus | muscleblind protein | 0.0295 | 0.2493 | 0.2406 |
Plasmodium vivax | hypothetical protein, conserved | 0.0366 | 0.3247 | 0.5 |
Mycobacterium leprae | PROBABLE CONSERVED LIPOPROTEIN LPQF | 0.0062 | 0.0016 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Echinococcus multilocularis | caspase 8 | 0.0366 | 0.3247 | 0.3169 |
Trypanosoma brucei | metacaspase | 0.0366 | 0.3247 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0295 | 0.2493 | 0.2406 |
Mycobacterium tuberculosis | Class a beta-lactamase BlaC | 0.0128 | 0.0726 | 1 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0366 | 0.3247 | 0.7744 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0893 | 0.2129 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Plasmodium falciparum | metacaspase 1 | 0.0366 | 0.3247 | 0.5 |
Trypanosoma brucei | metacaspase MCA2 | 0.0366 | 0.3247 | 1 |
Brugia malayi | hypothetical protein | 0.0089 | 0.0306 | 0.073 |
Echinococcus multilocularis | caspase 2 | 0.0455 | 0.4193 | 0.4126 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0366 | 0.3247 | 0.5 |
Mycobacterium ulcerans | class a beta-lactamase, BlaC | 0.0128 | 0.0726 | 1 |
Brugia malayi | Cell death protein 3 precursor | 0.0455 | 0.4193 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.0366 | 0.3247 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0295 | 0.2493 | 0.5945 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0893 | 0.2129 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1535 | 0.1437 |
Echinococcus multilocularis | caspase 3 | 0.0635 | 0.6113 | 0.6068 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Echinococcus granulosus | caspase 8 | 0.0366 | 0.3247 | 0.3169 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0089 | 0.0306 | 0.0194 |
Echinococcus multilocularis | muscleblind protein | 0.0295 | 0.2493 | 0.2406 |
Echinococcus granulosus | caspase 3 | 0.0635 | 0.6113 | 0.6068 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Leishmania major | metacaspase, putative | 0.0366 | 0.3247 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0366 | 0.3247 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0455 | 0.4193 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.0366 | 0.3247 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0366 | 0.3247 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.0366 | 0.3247 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0366 | 0.3247 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0071 | 0.0115 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0366 | 0.3247 | 0.5 |
Trypanosoma brucei | Metacaspase-4 | 0.0366 | 0.3247 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0089 | 0.0306 | 0.0194 |
Echinococcus granulosus | geminin | 0.0205 | 0.1535 | 0.1437 |
Brugia malayi | hypothetical protein | 0.0071 | 0.0115 | 0.0273 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0366 | 0.3247 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0366 | 0.3247 | 0.5 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.1001 | 1 | 1 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0366 | 0.3247 | 0.5 |
Echinococcus granulosus | caspase | 0.1001 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0366 | 0.3247 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0893 | 0.2129 |
Trypanosoma brucei | metacaspase MCA3 | 0.0366 | 0.3247 | 1 |
Echinococcus granulosus | caspase 2 | 0.0455 | 0.4193 | 0.4126 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0366 | 0.3247 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.0366 | 0.3247 | 0.5 |
Trypanosoma brucei | metacaspase 5, putative | 0.0366 | 0.3247 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0366 | 0.3247 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1535 | 0.1437 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.1001 | 1 | 1 |
Echinococcus multilocularis | caspase | 0.1001 | 1 | 1 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0455 | 0.4193 | 0.4126 |
Brugia malayi | Muscleblind-like protein | 0.0295 | 0.2493 | 0.5945 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0306 | 0.073 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1.4125 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.7783 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Saccharomyces cerevisiae | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.